Entera Bio (ENTX) Other Working Capital Changes (2021 - 2026)
Entera Bio (ENTX) recorded quarterly Other Working Capital Changes of $94000.0 in Q1 2026, up 840.0% on a QoQ basis from $10000.0 in Q4 2025, and down 71.77% year-over-year from $333000.0 in Q1 2025.
Entera Bio (ENTX) Other Working Capital Changes (2021 - 2026) Analysis & Trends
Entera Bio has disclosed Other Working Capital Changes across 6 years of filings, most recently posting $94000.0 for Q1 2026.
- Quarterly Other Working Capital Changes fell 71.77% year-over-year to $94000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$10000.0 (down 143.48% YoY) and the FY2025 annual result came in at $229000.0, up 1535.71% from the prior year.
- Other Working Capital Changes rose to $94000.0 in Q1 2026, from $10000.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $1.1 million in Q1 2022 and troughed at -$1.1 million in Q2 2022.
- A 5-year average of $18882.4 and a median of -$28000.0 in 2024 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2022 — Other Working Capital Changes surged 868.53% — and 2024, when it tumbled 2966.67%.
- Tracing ENTX's Other Working Capital Changes over 5 years: stood at -$340000.0 in 2022, then soared by 50.0% to -$170000.0 in 2023, then surged by 83.53% to -$28000.0 in 2024, then jumped by 135.71% to $10000.0 in 2025, then surged by 840.0% to $94000.0 in 2026.
- Business Quant data shows ENTX's Other Working Capital Changes at $94000.0 in Q1 2026, $10000.0 in Q4 2025, and -$33000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Entera Bio | 56.59 Mn | 52.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 94,000.00 |
| Mar 31, 2026 | 94,000.00 |
| Dec 31, 2025 | 10,000.00 |
| Dec 31, 2025 | 10,000.00 |
| Sep 30, 2025 | -33,000.00 |
| Sep 30, 2025 | -33,000.00 |
| Jun 30, 2025 | -81,000.00 |
| Jun 30, 2025 | -81,000.00 |
| Mar 31, 2025 | 333,000.00 |
| Mar 31, 2025 | 333,000.00 |
| Dec 31, 2024 | -28,000.00 |
| Dec 31, 2024 | -28,000.00 |
| Sep 30, 2024 | -190,000.00 |
| Sep 30, 2024 | -190,000.00 |
| Jun 30, 2024 | -92,000.00 |
| Jun 30, 2024 | -92,000.00 |
| Mar 31, 2024 | 324,000.00 |
| Mar 31, 2024 | 324,000.00 |
| Dec 31, 2023 | -170,000.00 |
| Dec 31, 2023 | -170,000.00 |